Pramipexole

GPTKB entity

Statements (34)
Predicate Object
gptkbp:instanceOf gptkb:drug
dopamine agonist
gptkbp:approvedBy 1997
gptkbp:ATCCode N04BC05
gptkbp:availableOn gptkb:tablet
extended-release tablet
gptkbp:brand Mirapex
Mirapexin
Sifrol
gptkbp:CASNumber 104632-26-0
gptkbp:chemicalFormula C10H17N3S
gptkbp:contraindication hypersensitivity to pramipexole
gptkbp:developedBy gptkb:Boehringer_Ingelheim
gptkbp:drugClass antiparkinsonian agent
dopaminergic agent
gptkbp:eliminationHalfLife 8-12 hours
gptkbp:excretion renal
https://www.w3.org/2000/01/rdf-schema#label Pramipexole
gptkbp:legalStatus prescription only
off-patent
gptkbp:mechanismOfAction dopamine D2 and D3 receptor agonist
gptkbp:metabolism minimal hepatic
gptkbp:molecularWeight 211.33 g/mol
gptkbp:pregnancyCategory C (US)
gptkbp:routeOfAdministration oral
gptkbp:sideEffect gptkb:orthostatic_hypotension
nausea
drowsiness
compulsive behaviors
hallucinations
gptkbp:usedFor gptkb:Parkinson's_disease
gptkb:restless_legs_syndrome
gptkbp:bfsParent gptkb:N04BB
gptkbp:bfsLayer 8